The cash boost comes from the UK Research Partnership Investment Fund (UK RPIF), which will deliver over £1 billion to support the development of new facilities and projects in areas including life sciences, energy and advanced manufacturing. The projects announced today are:
- A £48 million partnership between Manchester University, Christie Hospital and Cancer Research UK to develop the Institute for Cancer Research.
- An £85 million partnership between UCL (University College London) and the Great Ormond Street Hospital for The Centre for Children’s Rare Disease Research.
- A £32 million partnership between Queen’s University Belfast, The Atlantic Philanthropies and a Wellcome-Wolfson Capital Award to deliver the next phase of the Institute of Health Sciences.
- A £34 million partnership between the University of Nottingham and GlaxoSmithKline to support the Centre of Excellence in Sustainable Chemistry.
- A £38 million partnership between Swansea University, British Petroleum (BP), and TATA Steel Europe for the development of the Energy Safety Research Institute.
- A £60 million partnership between Brunel University, TWI and other companies to develop a National Research Centre for Structural Integrity.
- A £150 million partnership between Imperial College London and Voreda to contribute to the development of a major new campus adjacent to the White City regeneration area.
Universities will shortly be able to bid for the remaining £80 million of public investment from the fund. This must be matched by at least double from private sources.